Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol 280: L165-L172, 2001.-Mucus hypersecretion from hyperplastic airway goblet cells is a hallmark of chronic obstructive pulmonary disease (COPD). Although cigarette smoking is thought to be involved in mucus hypersecretion in COPD, the mechanism by which cigarette smoke induces mucus overproduction is unknown. Here we show that activation of epidermal growth factor receptors (EGFR) is responsible for mucin production after inhalation of cigarette smoke in airways in vitro and in vivo. In the airway epithelial cell line NCI-H292, exposure to cigarette smoke upregulated the EGFR mRNA expression and induced activation of EGFR-specific tyrosine phosphorylation, resulting in upregulation of MUC5AC mRNA and protein production, effects that were inhibited completely by selective EGFR tyrosine kinase inhibitors (BIBX1522, AG-1478) and that were decreased by antioxidants. In vivo, cigarette smoke inhalation increased MUC5AC mRNA and goblet cell production in rat airways, effects that were prevented by pretreatment with BIBX1522. These effects may explain the goblet cell hyperplasia that occurs in COPD and may provide a novel strategy for therapy in airway hypersecretory diseases.
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human goblet factor; airway epithelial differentiation TWENTY-SIX PERCENT OF THE smoking-attributable deaths involve obstructive airway diseases (e.g., emphysema, chronic bronchitis) (23) . The hallmarks of chronic bronchitis are cough and excessive mucus production (1) . Exposure to cigarette smoke is reported to induce goblet cell hyperplasia and mucus production in several species (3, 18) , but the mechanism is not known.
Mucin MUC5A is a major mucin in the airway epithelium (14, 26) . Recently, mucin synthesis in airways has been reported to be regulated by the epidermal growth factor receptor (EGFR) system (28) : activation of EGFR tyrosine kinase by its ligands leads to the synthesis of mucin MUC5AC at both mRNA and protein levels in airway epithelial cells in vitro and causes mucin MU5AC production and goblet cell metaplasia in rats in vivo (28) .
Oxidative stress also has been shown to cause EGFR activation, which results in stimulation of mucin synthesis in airway epithelial cells (29) . From these findings, we hypothesized that cigarette smoke, a major exogenous source of oxidative stress, induces mucin synthesis and subsequent goblet cell production via an EGFR signaling pathway. To examine this hypothesis, we tested whether cigarette smoke causes mucin MUC5AC synthesis, and, if so, whether EGFR activation is involved. We performed in vitro studies in bronchial epithelial (NCI-H292) cells, which are known to produce MUC5AC mucins, and in vivo studies in specific pathogen-free rats (a species that normally has few goblet cells constitutively). Here we show that cigarette smoke upregulates EGFR expression and induces mucin synthesis via EGFR activation in the airway epithelium in vitro and in vivo. Inhibition of the EGFR signaling pathway may be useful therapeutically in preventing the hypersecretion that occurs in chronic obstructive pulmonary disease (COPD).
MATERIAL AND METHODS

In Vitro Studies
Preparation of cigarette smoke solution. Standard research cigarettes (code 2R1, produced for the University of Kentucky Tobacco and Health Research Foundation) were used in the study. Cigarette smoke solution was prepared as described previously (10) . In brief, cigarette smoke was withdrawn into a polypropylene syringe (35 ml) at a rate of one puff/min (10 times) and bubbled slowly into 20 ml of RPMI 1640 medium containing 50 mM HEPES buffer. The smoke solution was then titrated to pH 7.4 and used immediately after preparation.
Cell culture. NCI-H292 cells, a human pulmonary mucoepidermoid carcinoma cell line, were grown in RPMI 1640 medium containing 10% fetal bovine serum, penicillin (100 U/ml), streptomycin (100 g/ml), and HEPES (25 mM) at 37°C in a humidified 5% CO 2 water-jacketed incubator. Either six-well culture plates or eight-chamber slides were used to culture the cells. When confluent, cells were incubated for 1 h with cigarette smoke solution. The cells were then washed and incubated with fresh medium alone. Experiments were terminated at preselected times (for mRNA, 6 and 12 h; for protein, 24 h). As controls, cells were incubated with medium alone for the same time periods. In inhibition studies with EGFR tyrosine kinase inhibitors, NCI-H292 cells were pretreated with BIBX1522 (10 g/ml; generously provided by Boehringer Ingelheim Pharma, Ingelheim, Germany) or tyrphostin AG-1478 (10 M; Calbiochem) 30 min before the cigarette smoke solution was delivered. The effects of a selective inhibitor of platelet-derived growth factor receptor tyrosine kinase (tyrphostin AG-1295, 100 M; Calbiochem), and a negative control for tyrphostins (tyrphostin A1, 100 M; Calbiochem) were also examined. The role of reactive oxygen species was examined using a scavenger of oxygen-free radicals, DMSO (1%; Sigma), or superoxide dismutase (SOD, 300 U/ml; Sigma). The doses were determined from previous studies (6, 7, 20, 24) .
Immunoblotting for activated EGFR. Cells were serum starved for 24 h and then stimulated with cigarette smoke solution or with transforming growth factor-␣ (TGF-␣) for 15 min. After stimulation, cells were lysed with lysis buffer (20 mM sodium phosphate, pH 7.8, 150 mM NaCl, 5 mM EDTA, 50 mM HEPES, 1% Triton X-100, 50 mM NaF, 1 mM sodium orthovanadate, 5 mM phenylmethylsulfonyl fluoride, and 10 g/ml each of leupeptin and aprotinin) and incubated for 30 min at 4°C. To remove insoluble materials, cell lysates were centrifuged at 14,000 rpm for 5 min at 4°C. Aliquots of supernatants containing equal amounts of protein were suspended in SDS sample buffer and boiled for 5 min. Proteins were separated by SDS-PAGE in 4-15% acrylamide gels. The resulting gel was equilibrated in the transfer buffer: 25 mM Tris ⅐ HCl, 192 mM glycine, and 20% (vol/vol) methanol, pH 8.3. The proteins were then transferred electrophoretically to nitrocellulose membranes, which were incubated with 5% fat-free skimmed milk in phosphate-buffered saline (PBS) containing 0.05% Tween 20 for 1 h and then incubated with anti-phospho-specific EGFR monoclonal antibodies (2 g/ml; Calbiochem) overnight. Bound antibodies were visualized according to a standard protocol for the avidin-biotin-alkaline phosphatase complex method (ABC kit; Vector Laboratories, Burlingame, CA).
In situ hybridization of EGFR mRNA and MUC5AC mRNA. In situ hybridization was performed using a human EGFR probe, which contained a 350-bp cDNA fragment of the human EGFR gene (pTRI-EGFR-human probe template; Ambion, Austin, TX) and a human MUC5AC probe, which contained a 298-bp cDNA fragment of the human MUC5AC gene (generously provided by Dr. Carol Basbaum). The 350-bp cDNA human EGFR was subcloned into pBluescript II SK Ϫ vector at Kpn I and EcoR I sites. This pBluescript was used to generate human EGFR antisense and sense probes. Hybridization was performed as described previously (19) . In brief, the cells grown on the eight-chamber slides were fixed in 4% paraformaldehyde, rehydrated in 0.5ϫ saline-sodium citrate (SSC), and then acetylated in triethanolamine and acetic anhydride. Hybridization was carried out with 2,500-4,000 counts ⅐ min Ϫ1 ⅐ l Ϫ1 of antisense or sense probe in 50% deionized formamide, 0.3 M NaCl, 20 mM Tris, 5 mM EDTA, 1ϫ Denhardt's solution, 20 mM dithiothreitol, 10% dextran sulfate, 0.5 mg/ml yeast tRNA, and 0.5 mg/ml sonicated salmon sperm DNA at 58°C overnight. Posthybridization treatment consisted of washes with 2ϫ SSC, 1 mM EDTA, and 10 mM ␤-mercaptoethanol at room temperature, incubation with RNase solution (20 g/ml) for 30 min at room temperature, and further washes in 0.1ϫ SSC, 1 mM EDTA, and 10 mM ␤-mercaptoethanol at 55°C for 2 h and then in 0.5ϫ SSC at room temperature for 20 min. Specimens were dehydrated, air-dried, and covered with Kodak nitro blue tetrazolium nuclear track emulsion (Eastman Kodak, Rochester, NY) for autoradiography. After exposure for 7-21 days at 4°C, the slides were developed, fixed, and counterstained with hematoxylin.
Immunoassay of MUC5AC protein. MUC5AC protein was measured as described previously (28) . In brief, cell lysates were prepared with PBS at multiple dilutions, and 50 l of each sample were incubated with bicarbonate-carbonate buffer (50 l) at 40°C in a 96-well plate (Maxisorp Nunc; Fisher Scientific, Santa Clara, CA) until dry. Plates were washed three times with PBS and blocked with 2% bovine serum albumin, fraction V (Sigma), for 1 h at room temperature. Plates were again washed three times with PBS and then incubated with 50 l of MUC5AC monoclonal antibodies (clone 45 1, 1:100; NeoMarkers, Fremont, CA) that were diluted with PBS containing 0.05% Tween 20. After 1 h, the wells were washed three times with PBS, and 100 l of horseradish peroxidase-goat anti-mouse IgG conjugate (1:10,000) were dispensed into each well. After 1 h, plates were washed three times with PBS. Color reaction was developed with 3,3Ј,5,5Ј-tetramethylbenzidine peroxidase solution (Kirkegaard and Perry Laboratories, Gaithersburg, MD) and stopped with 2 N H 2 SO 4 . Absorbance was read at 450 nm.
In Vivo Studies
Drugs. A stock solution of BIBX1522 was prepared using Solutol HS 15 (polyethylene-660-hydroxystearate; Badische Anilin und Soda Fabrik) as a solvent. This solution was evaporated to dryness. The residue was redissolved in 0.3 ml of methanol and once again evaporated to dryness. This stock preparation was stored at 4°C for 5 days. The solution for intratracheal instillation was made up fresh each day by dissolving the stock preparation in 3 ml of prewarmed saline (40°C) to achieve final concentrations of 0.1 and 0.3%.
Induction of goblet cell metaplasia by cigarette smoke exposure. Male Sprague-Dawley rats weighing 250-300 g were used for the study. The animals were housed in a temperature-and humidity-controlled room and had free access to water and standard laboratory food. Animals were assigned at random to the nonsmoking control group or to the smokeexposed control and treatment groups. Rats in the smoking groups were exposed to eight regular, nonfilter cigarettes (1.2 mg nicotine, 12 mg condensate) a day for 5-20 days.
On each day of exposure, 12 animals were placed individually in wire-mesh cages inside a Plexiglas cabinet (40 ϫ 50 ϫ 20 cm). Cigarette smoke was delivered into the cabinet by passing air at a flow rate of 0.3 ml/s through a burning cigarette in a chamber. The combustion time of the cigarette was ϳ3 min. A ventilator inside the cabinet ensured a rapid and equal distribution of the smoke. Fresh air at a flow rate of 2 l/min was delivered into the cabinet to remove the smoke. At intervals of 30 min, the smoke of a new cigarette was conducted into the cabinet. During the exposure time of 4 h, no animal, including control animals, received food or water. At other times, the animals had free access to food and water.
Inhibition of cigarette smoke-induced goblet cell metaplasia by the EGFR kinase inhibitor BIBX1522. To evaluate the effect of EGFR kinase inhibitor on goblet cell metaplasia and mucus production, the animals were treated once daily with vehicle or with BIBX1522 at doses of 1 or 3 mg/kg intratracheally 1 h before the exposure to cigarette smoke. Treatment of the animals with vehicle or BIBX1522 started on day 1 and was continued for 5 days during exposure to cigarette smoke. The intratracheal instillation in a volume of 1 ml/kg was performed under isoflurane anesthesia.
RNA isolation and quantification. Eight hours after the last exposure to cigarette smoke, the animals were euthanized with pentobarbital sodium. The trachea and right main stem bronchus were removed and processed for total RNA isolation using a Qiagen RNeasy kit according to the manufacturer's instructions. For RNA quantification, the real-time PCR technology (TaqMan-PCR, ABI Prism 7700 Sequence Detection System; PerkinElmer Applied Biosystems, Foster City, CA) was employed. This technology has been described in detail elsewhere (11) . Briefly, during PCR cycles, the 5Ј-fluorescent-labeled nucleotide is released from the probe by exonuclease activity of the TaqPolymerase; the emission of fluorescence is detected via laser, and during proceeding PCR cycles, an increasing fluorescence above background is measured and documented. The signal is normalized in relation to an internal reference signal, and the software sets the threshold cycle when the difference to the reference signal is more than 10-fold of standard deviation. The threshold cycle value is used for quantification of the input target number.
Primers and probes for rat MUC5AC were designed using the PrimerExpress 1.0 program provided by PerkinElmer. The following sequences were used for the quantification of the rat MUC5AC: forward primer 5Ј-TGG GAA CCA TCA TCT ACA ACC A-3Ј, reverse primer 5Ј-TCC TGA CTA ACC CCT TTG ACC A-3Ј, and the FAM reporter dye-labeled hybridization probe 5Ј-CCT TGA CGG CCA CTG TTA CTA TGC GAT GT-3Ј.
Primers and probe for ribosomal RNA were purchased from Biosystems Deutschland [TaqMan Ribosomal RNA Control Reagents (VIC Probe), Patent No. 4308329]. RT-PCR and TaqMan PCR were performed in a one-step RT-PCR using the TaqMan EZ RT-PCR Core Reagents; forward primer 50 nM, reverse primer 300 nM, probe 100 nM, manganese acetate 2.5 mM; total RNA ϳ5-10 ng; enzymes, reaction buffer and nucleotides according to the manufacturer's protocol (TaqMan EZ RT-PCR Kit, PerkinElmer P/N 402877 Rev. A, 1996). Cycles were 10 min at 50°C, 30 min at 60°C, 5 min at 95°C, 40 times 20 s at 94°C, and 1 min at 59°C. To quantify the mRNA expression, the target gene was first normalized to the ribosomal RNA as internal standard. The data were then expressed as the relative amount of MUC5AC compared with a standard control tissue.
Tissue preparation and quantification of goblet cell production. The lungs were dissected and fixed in 7% buffered Formalin and embedded in paraffin. The left main stem bronchus was used for immunohistochemical staining. Lung sections were cut to include the full length of the main intrapulmonary airway and stained sequentially with hematoxylin and eosin or with Alcian blue (AB)-periodic acidSchiff (PAS) to evaluate the total epithelial area and the area stained for intracellular mucous glycoconjugates, respectively. Goblet cell production was determined by the volume density of AB-PAS-stained mucous glycoconjugates on the epithelial mucosal surface using an image analysis system (Soft Imaging System, Mü nster, Germany). The AB-PASpositive stained area, the number of goblet cells, and the total epithelial area were measured over a length of 2 mm of the basal lamina. The stained areas are expressed as the percentage of the total area stained by AB-PAS.
Tissue preparation. Surgical specimens were fixed with 4% paraformaldehyde for 1 h and then placed in 30% sucrose for cryoprotection overnight. The specimens were embedded in optimal cutting temperature compound and cut as 4-mthick sections.
Immunohistochemical analysis of EGFR. Immunohistochemistry was performed using frozen sections. Sections were refixed with 4% paraformaldehyde for 5 min. PBS containing 0.05% Tween 20, 2% normal goat serum, and Levamisol (2 mM) was used as diluent for the antibodies. The sections were incubated with mouse monoclonal antibody to EGFR (1:200; Calbiochem, San Diego, CA) for 2 h at room temperature and then washed three times with PBS to remove excess primary antibody. The sections were then incubated with biotinylated horse anti-mouse IgG (Vector Laboratories) at 1:200 dilution for 1 h at room temperature. Bound antibody was visualized according to standard protocols for the avidin-biotin-alkaline phosphatase complex method. All immunohistochemical staining included control sections unexposed to primary antibody, with substitution of an unrelated antibody of the same isotype or preincubation of the antibody with a 10-fold excess of immunizing peptide. A rabbit polyclonal antibody to EGFR (1:100, Calbiochem) also was used to confirm the staining pattern and to perform quenching using EGFR peptide antigen, which corresponds to amino acid residues 1005-1016 of the human EGFR (Calbiochem).
Statistics
All data are expressed as means Ϯ SE. One-way analysis of variance (ANOVA) was used to determine statistically significant differences between groups. Scheffé's F-test was used to correct for multiple comparisons when statistical significances were identified in the ANOVA. P Ͻ 0.05 for the null hypothesis was accepted as indicating a statistically significant difference.
RESULTS
In Vitro Studies in NCI-H292 Cells
Cigarette smoke upregulates EGFR mRNA expression. In the control condition, NCI-H292 cells expressed EGFR mRNA constitutively. Addition of cigarette smoke solution to the cells upregulated EGFR mRNA expression within 6 h, an effect that was increased at 12 h. Tumor necrosis factor-␣ (TNF-␣, used as control) also increased EGFR mRNA expression. The sense probe of EGFR showed no expression (Fig. 1) .
Cigarette smoke activates EGFR tyrosine phosphorylation. Because the activation of EGFR by its ligands leads to MUC5AC synthesis (28), we examined the effect of cigarette smoke solution on activation of EGFR tyrosine kinase. As a positive control, we used the EGFR ligand TGF-␣, which increased EGFR-specific tyrosine phosphorylation in NCI-H292 cells (Fig.  2) , as described previously (28) . Similarly, cigarette smoke solution increased EGFR-specific tyrosine phosphorylation but to a lesser extent (Fig. 2) . Pretreatment of NCI-H292 cells with BIBX1522 inhibited EGFR tyrosine phosphorylation induced by cigarette smoke solution and by TGF-␣ (Fig. 2) .
Cigarette smoke increases MUC5AC expression. Resting NCI-H292 cells showed little expression of MUC5AC mRNA at 12 h. Addition of cigarette smoke solution to the cells upregulated MUC5AC mRNA expression within 6 h (data not shown), an effect that was increased at 12 h (Fig. 3) . TGF-␣ (used as control) also increased MUC5AC mRNA expression. The sense probe of MUC5AC showed no expression. Similarly, cigarette smoke solution increased MUC5AC protein synthesis within 24 h, an effect that occurred in a dose-dependent fashion (Fig. 4) .
EGFR tyrosine kinase inhibitors prevent MUC5AC gene and protein expression in NCI-H292 cells.
To test whether the cigarette smoke-induced MUC5AC gene and protein expression occurred by activation of EGFR, cells were incubated with various tyrosine kinase inhibitors. Pretreatment of the cells with selective EGFR tyrosine kinase inhibitors (BIBX1522, AG-1478) prevented MUC5AC mRNA expression (Fig. 3) and MUC5AC protein synthesis induced by cigarette smoke solution (Fig. 4) . A selective tyrosine kinase inhibitor of platelet-derived growth factor (AG-1295) and a negative control for tyrphostins (A1) were without effect (Fig. 4) . Furthermore, cigarette smoke-induced MUC5AC synthesis was inhibited significantly by pretreatment with a free radical scavenger (DMSO) and by SOD. These results indicate that activation of EGFR tyrosine kinase induces MUC5AC gene and protein expression in NCI-H292 cells and that oxidative stress induced by cigarette smoke is involved, at least in part, in cigarette smoke-induced MUC5AC production.
In Vivo Studies in Rats
Cigarette smoke increases goblet cell production in pathogen-free rats. In control animals, the airway epithelium contained sparse staining with AB-PAS (Figs. 5 and 6A). Inhalation of cigarette smoke (8 cigarettes/ day for 5 days) resulted in a markedly increased area of AB-PAS staining (Figs. 5 and 6B) . Inhalation of cigarette smoke also increased the number of goblet cells from 40 Ϯ 19 to 167 Ϯ 19 cells/mm of epithelium (P Ͻ 0.001). Inhalation of cigarette smoke also increased MUC5AC mucin gene expression (Fig. 7) .
EGFR tyrosine kinase inhibitor (BIBX1522) prevents cigarette smoke-induced goblet cell production in pathogen-free rats. When rats were treated with BIBX1522 during cigarette smoking, the increase in AB-PAS staining was inhibited dose dependently (Figs. 5 and 6C) , and the cigarette smoke-induced increase in the number of goblet cells was also prevented by BIBX1522 (3 mg/kg intratracheally). In BIBX1522-treated rats given cigarette smoke, there were 51 Ϯ 19 cells/mm epithelium; P Ͼ 0.05 compared with control. BIBX1522 also prevented the cigarette smoke-induced MUC5AC gene expression (Fig. 7) . Proteins were separated by SDS-PAGE in 4-15% acrylamide gels and blotted with anti-phospho-specific EGFR antibodies. In inhibition studies, NCI-H292 cells were pretreated with a selective EGFR tyrosine kinase inhibitor (BIBX1522) for 30 min. In control cells, EGFR-specific tyrosine phosphorylation was low. Cigarette smoke increased EGFR-specific tyrosine phosphorylation in NCI-H292 cells, an effect that was inhibited by BIBX1522. Results are representative of 3 separate experiments. Bar, 170 kDa. 
DISCUSSION
In the present study, we have addressed the question of whether cigarette smoke increases mucin MUC5AC synthesis via EGFR activation in airway epithelial cells. Our results show that exposure of airway epithelial cells to cigarette smoke upregulates EGFR expression and activates EGFR tyrosine phosphorylation, causing mucin MUC5AC synthesis in NCI-H292 cells.
Pretreatment with selective EGFR tyrosine kinase inhibitors prevented cigarette smoke-induced EGFR tyrosine phosphorylation and MUC5AC synthesis in vitro; a non-EGFR tyrosine kinase inhibitor, a selective platelet-derived growth factor receptor kinase inhibitor (AG-1295), and a negative control for tyrphostins (A1) were without effect, implicating EGFR tyrosine phosphorylation as the signaling pathway of MUC5AC synthesis induced by cigarette smoke. Most importantly, the present studies show for the first time that an EGFR tyrosine kinase inhibitor prevents cigarette smoke-induced MUC5AC synthesis in vivo and in vitro.
The mechanism by which cigarette smoke induces EGFR activation requires discussion. To induce EGFR activation, two different pathways have been reported. First, the binding of its ligands to EGFR activates the intrinsic receptor tyrosine kinase and induces tyrosine phosphorylation (15) . Second, tyrosine phosphorylation of EGFR can be activated by a ligand-independent mechanism ("transactivation"). EGFR transactivation is known to occur with various stimuli such as oxidative H 2 O 2 (12, 13) , ultraviolet light (27) , and osmotic stress (27) , and with stimulation of G protein-coupled receptors by endothelin 1, lysophosphatidic acid, and thrombin (5), M 1 muscarinic acetylcholine receptor (31) and growth hormone (32) . In our experiments, antioxidants (DMSO, SOD) partially inhibited MUC5AC synthesis induced by cigarette smoke. Thus oxidative stress is one of the mechanisms producing cigarette smoke-induced EGFR activation in airway epithelium. Indeed, it has been reported that oxidative stress induced by neutrophils or by H 2 O 2 causes MUC5AC synthesis via the EGFR-mitogen-activated protein kinase kinase-p44/42 mitogen-activated protein kinase pathway in vitro (29) . Interestingly, cigarette smoke also is known to cause neutrophil migration into the airways (22) . Thus MUC5AC synthesis in vivo might be caused both via the direct stimulation of cigarette smoke and via indirect stimulation resulting from neutrophil recruitment, activation, and release of oxygen free radicals induced by inhalation of cigarette smoke.
Although ϳ50% of cigarette smoke-induced EGFR activation and mucin synthesis was explained by oxidative stress, the remainder of the EGFR activation and subsequent mucin synthesis induced by cigarette smoke is unknown. Because cigarette smoke-induced goblet cell metaplasia in rats has been reported to be prevented by pretreatment with an inhibitor of cyclooxygenase products, indomethacin (25) , the products of the arachidonate cascade might be involved in cigarette smoke-induced EGFR activation. Indeed, a link between EGFR activation and the arachidonate cascade has been reported. Arachidonic acid induces EGFR tyrosine phosphorylation and its association with Shc, resulting in mitogen-activated protein kinase activation in epithelial cells of rabbit renal proximal tubules (9) . In addition, acrolein, a product of cigarette smoke, is reported to induce MUC5AC expression in rat airways (2) . Interestingly, acrolein also is reported to produce cyclooxygenase products (prostaglandins E 2 and F 2␣ ) in airway epithelial cells (8, 16) . Thus the inhibitory effect of indomethacin on cigarette smokeinduced goblet cell metaplasia may be due to the prostaglandin synthesis induced by acrolein. Taken together, cigarette smoke-induced EGFR activation and subsequent mucin synthesis in airways could be caused in part by the cyclooxygenase products that are upregulated by cigarette smoke. Further studies are required to determine the effects of various components of cigarette smoke (e.g., nicotine, tar, acrolein). Another factor possibly involved in cigarette smokeinduced EGFR activation is the upregulation of EGFR ligands. Oxidative stress has been shown to increase gene expression of the EGFR ligands, heparin-binding EGF-like growth factor and amphiregulin, in rat gastric epithelial cells (21) . Thus it is possible that cigarette smoke, by upregulating EGFR ligands, could activate EGFR to induce mucin synthesis.
Another mechanism by which cigarette smoke may enhance MUC5AC synthesis is upregulation of EGFR expression. In the present study, we found that cigarette smoke upregulated EGFR mRNA expression in NCI-H292 cells and that strong EGFR immunoreactiv- Fig. 6 . Photomicrographs of the effect of cigarette smoke on AB-PAS staining of airway epithelium in pathogenfree rats. Epithelium of control rats showed little staining (A), but inhalation of cigarette smoke increased AB-PAS staining markedly (B). Treatment with the selective EGFR tyrosine kinase inhibitor (BIBX1522) prevented cigarette smoke-induced increase in AB-PAS staining (C). Photomicrographs shown at ϫ10 magnification and insets shown at ϫ40 magnification are typical of the animals studied in each. Arrows, AB-PAS-positive cells. Bars, 25 m. Fig. 7 . Effect of inhalation of cigarette smoke on MUC5AC mRNA expression in tracheobronchial tissue in pathogen-free rats and effect of an EGFR tyrosine kinase inhibitor (BIBX1522, 1-3 mg/kg intratracheally) on cigarette smoke-induced MUC5AC mRNA expression (n ϭ 5/group). † † P Ͻ 0.001, significantly different from control animals; * P Ͻ 0.001, significantly different from animals given cigarette smoke alone. ity was observed in airway goblet cells in patients with COPD. Similarly, a previous study showed that strong EGFR immunoreactivity was found in the bronchial epithelium of smokers (17) . Thus cigarette smoke-induced goblet-cell production may involve both upregulation of EGFR expression and subsequent EGFR activation in COPD.
Regardless of the multiple mechanisms in addition to oxidative stress potentially involved, the fact that cigarette smoke-induced mucin synthesis was blocked completely by EGFR tyrosine kinase inhibitors indicates that EGFR activation has a principal role in cigarette smoke-induced MUC5AC synthesis.
In humans, we suggest that the EGFR cascade in glands could be important in the exaggerated mucus production in conducting airways in chronic bronchitis (1) in which the excessive sputum is believed to be derived largely from hyperplastic glands (30) . Furthermore, prolonged cigarette smoking has been suggested to be associated with pathological changes in peripheral airways, including goblet cell hyperplasia (4). These results implicate cigarette smoke as a regulator of epithelial cell differentiation that may result in abnormal induction of mucin-producing cells in airways. Most importantly, inhibition of EGFR activation is proposed as therapy in hypersecretory airway diseases. Proof of the concept in humans will require testing of patients with these diseases.
